Table 2.
Main drainage vein, Hirota’s grade, and change in eGFR from before to after the procedure in each group
| G1 | G ≥ 2 | GERTO | Overall | |
|---|---|---|---|---|
| group | group | group | rate | |
| (n = 20) | (n = 17) | (n = 20) | (n=57) | |
| Main drainage vein | ||||
| GR shunt | 18 | 15 | 16 | 86% |
| GC shunt | 2 | 2 | 3 | 12% |
| PCV | 0 | 0 | 1 | 1.8% |
| Hirota’s Grade | a p = 0.03 | |||
| 1 | 20 | - | - | |
| 2 | - | 7 | 2 | |
| 3 | - | 6 | 6 | |
| 4 | - | 4 | 12 | |
| 5 | - | 0 | 0 | |
| Pre-eGFR (mL/min/1.73 m2) | 70.6 ± 19.0 | 77.1 ± 25.0 | 78.1 ± 17.4 | |
| Post-eGFR (mL/min/1.73 m2) | 66.3 ± 21.1 | 77.1 ± 26.4 | 81.6 ± 19.2 | |
| bp value | 0.13 | 0.91 | 0.33 | |
EOI, ethanolamine oleate iopamidol; GC, gastrocaval; GERTO, retrograde transvenous obliteration; GR, gastrorenal; PCV, pericardial vein;eGFR, estimate glomerular filtration rat.
Data are shown as mean ± standard deviation, or number.
a
Variables analyzed using Fisher exact probability test about 5% EOI group and 5% EOI containing GS Particles Group in Grade 2–5.
b
Variables analyzed using fisher exact propability test.